Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antifibrotic Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antifibrotic Drugsmarket, defines the market attractiveness level of Antifibrotic Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antifibrotic Drugs industry, describes the types of Antifibrotic Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antifibrotic Drugs market and the development prospects and opportunities of Antifibrotic Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antifibrotic Drugs market in Chapter 13.
By Player:
Bristol-Myers Squibb
Bayer
Boehringer Ingelheim
Roche
Novartis
Merck
Sanofi
Pfizer
By Type:
Oral
Injectable
Topical
By End-User:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antifibrotic Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antifibrotic Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antifibrotic Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antifibrotic Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antifibrotic Drugs Market Analysis and Outlook to 2022
-
7.1 Global Antifibrotic Drugs Consumption (2017-2022)
-
7.2 United States Antifibrotic Drugs Consumption (2017-2022)
-
7.3 Europe Antifibrotic Drugs Consumption (2017-2022)
-
7.4 China Antifibrotic Drugs Consumption (2017-2022)
-
7.5 Japan Antifibrotic Drugs Consumption (2017-2022)
-
7.6 India Antifibrotic Drugs Consumption (2017-2022)
-
7.7 South Korea Antifibrotic Drugs Consumption (2017-2022)
8 Region and Country-wise Antifibrotic Drugs Market Analysis and Outlook to 2028
-
8.1 Global Antifibrotic Drugs Consumption Forecast (2022-2028)
-
8.2 United States Antifibrotic Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Antifibrotic Drugs Consumption Forecast (2022-2028)
-
8.4 China Antifibrotic Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Antifibrotic Drugs Consumption Forecast (2022-2028)
-
8.6 India Antifibrotic Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Antifibrotic Drugs Consumption Forecast (2022-2028)
9 Global Antifibrotic Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Antifibrotic Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injectable Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Topical Consumption and Growth Rate (2017-2022)
-
9.2 Global Antifibrotic Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Antifibrotic Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Antifibrotic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injectable Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antifibrotic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Antifibrotic Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antifibrotic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antifibrotic Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antifibrotic Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antifibrotic Drugs Market Competitive Analysis
-
14.1 Bristol-Myers Squibb
-
14.1.1 Bristol-Myers Squibb Company Details
-
14.1.2 Bristol-Myers Squibb Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bristol-Myers Squibb Antifibrotic Drugs Product and Service
-
14.2 Bayer
-
14.2.1 Bayer Company Details
-
14.2.2 Bayer Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bayer Antifibrotic Drugs Product and Service
-
14.3 Boehringer Ingelheim
-
14.3.1 Boehringer Ingelheim Company Details
-
14.3.2 Boehringer Ingelheim Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Boehringer Ingelheim Antifibrotic Drugs Product and Service
-
14.4 Roche
-
14.4.1 Roche Company Details
-
14.4.2 Roche Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Roche Antifibrotic Drugs Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Antifibrotic Drugs Product and Service
-
14.6 Merck
-
14.6.1 Merck Company Details
-
14.6.2 Merck Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Antifibrotic Drugs Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Antifibrotic Drugs Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Antifibrotic Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antifibrotic Drugs
-
Figure Antifibrotic Drugs Picture
-
Table Global Antifibrotic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antifibrotic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antifibrotic Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antifibrotic Drugs Consumption by Country (2017-2022)
-
Figure United States Antifibrotic Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Antifibrotic Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Antifibrotic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Antifibrotic Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Antifibrotic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antifibrotic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Antifibrotic Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Antifibrotic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antifibrotic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antifibrotic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antifibrotic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antifibrotic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antifibrotic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injectable Consumption and Growth Rate (2017-2022)
-
Figure Global Topical Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injectable Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antifibrotic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antifibrotic Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Antifibrotic Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Antifibrotic Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Antifibrotic Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Antifibrotic Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Antifibrotic Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Antifibrotic Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Antifibrotic Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Antifibrotic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Antifibrotic Drugs Product and Service
-
